Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial.
Guigay J, Aupérin A, Fayette J, Saada-Bouzid E, Lafond C, Taberna M, Geoffrois L, Martin L, Capitain O, Cupissol D, Castanie H, Vansteene D, Schafhausen P, Johnson A, Even C, Sire C, Duplomb S, Evrard C, Delord JP, Laguerre B, Zanetta S, Chevassus-Clément C, Fraslin A, Louat F, Sinigaglia L, Keilholz U, Bourhis J, Mesia R; GORTEC; AIO; TTCC, and UniCancer Head and Neck groups. Guigay J, et al. Among authors: lafond c. Lancet Oncol. 2021 Apr;22(4):463-475. doi: 10.1016/S1470-2045(20)30755-5. Epub 2021 Mar 5. Lancet Oncol. 2021. PMID: 33684370 Clinical Trial.
[Oropharyngeal cancer].
Lafond C, Pointreau Y, Debelleix C, Denis F, Calais G, Bourhis J, Thariat J. Lafond C, et al. Cancer Radiother. 2010 Nov;14 Suppl 1:S34-42. doi: 10.1016/S1278-3218(10)70006-8. Cancer Radiother. 2010. PMID: 21129668 French.
A Nomogram to predict parotid gland overdose in head and neck IMRT.
Castelli J, Simon A, Rigaud B, Lafond C, Chajon E, Ospina JD, Haigron P, Laguerre B, Loubière AR, Benezery K, de Crevoisier R. Castelli J, et al. Among authors: lafond c. Radiat Oncol. 2016 Jun 8;11:79. doi: 10.1186/s13014-016-0650-6. Radiat Oncol. 2016. PMID: 27278960 Free PMC article.
[Radiotherapy of larynx cancers].
Pointreau Y, Lafond C, Legouté F, Trémolières P, Servagi-Vernat S, Giraud P, Maingon P, Calais G, Lapeyre M. Pointreau Y, et al. Among authors: lafond c. Cancer Radiother. 2016 Sep;20 Suppl:S131-5. doi: 10.1016/j.canrad.2016.07.018. Epub 2016 Aug 9. Cancer Radiother. 2016. PMID: 27521037 French.
[Radiotherapy of hypopharynx cancers].
Pointreau Y, Lafond C, Trémolières P, Legouté F, Servagi-Vernat S, Giraud P, Maingon P, Calais G, Lapeyre M. Pointreau Y, et al. Among authors: lafond c. Cancer Radiother. 2016 Sep;20 Suppl:S126-30. doi: 10.1016/j.canrad.2016.07.020. Epub 2016 Aug 10. Cancer Radiother. 2016. PMID: 27522185 French.
[Nasal cavity and paranasal sinus cancer].
Peyraga G, Lafond C, Pointreau Y, Giraud P, Maingon P. Peyraga G, et al. Among authors: lafond c. Cancer Radiother. 2016 Sep;20 Suppl:S99-S103. doi: 10.1016/j.canrad.2016.07.035. Epub 2016 Aug 12. Cancer Radiother. 2016. PMID: 27528562 French.
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study.
Bourgeois H, Grudé F, Solal-Céligny P, Dupuis O, Voog E, Ganem G, Denis F, Zinger M, Juhel-Voog L, Lafond C, Maillart P, Capitain O, Delva R, Soulié P, Abadie-Lacourtoisie S, Guérin-Meyer V, Morin-Meschin ME, Commer JM, Gangler A, d'Aillières B, Zannetti A, Bourbouloux E, Berton-Rigault D, Lebouvier-Sadot S, Kaassis M, Baudon J, Lam YH, Bizieux A, Marcq M, Edeline J, Le Du F, Lefeuvre C, Deguiral P, Delecroix V, Blot E, Egreteau J, Goudier MJ, Lamy R, Ferec M, Artignan X, Corbinais S, Morel H, Hardy-Bessard AC, Alleaume C, Naudeix E, Cojocarasu O, Metges JP, Riché C, Gamelin E, Déniel-Lagadec D, Marhuenda F, Ingrand P, Douillard JY. Bourgeois H, et al. Among authors: lafond c. Ann Oncol. 2017 Jul 1;28(7):1612-1617. doi: 10.1093/annonc/mdx172. Ann Oncol. 2017. PMID: 28472235 Free article.
Adaptive radiotherapy in head and neck cancer is required to avoid tumor underdose.
Castelli J, Simon A, Rigaud B, Chajon E, Thariat J, Benezery K, Vauleon E, Jegoux F, Henry O, Lafond C, de Crevoisier R. Castelli J, et al. Among authors: lafond c. Acta Oncol. 2018 Sep;57(9):1267-1270. doi: 10.1080/0284186X.2018.1468086. Epub 2018 Apr 28. Acta Oncol. 2018. PMID: 29706107 No abstract available.
123 results